ImmunoCellular Therapeutics, Ltd.(IMUC)- NYSEMKT
Company Description
ImmunoCellular Therapeutics Ltd. is a Los Angeles-based clinical-stage company that develops immune-based therapies for the treatment of brain and other cancers. ImmunoCellular's pipeline includes: ICT-121, a dendritic cell immunotherapy targeting the CD133 antigen on stem cells in recurrent... More
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: United States